GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $2.90 $4.87 Friday, 27th Jan 2023 CLBS stock ended at $3.55. This is 1.14% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 1.43% from a day low at $3.50 to a day high of $3.55.
90 days $2.90 $4.87
52 weeks $0.402 $9.75

Historical Caladrius Biosciences prices

Date Open High Low Close Volume
2022-07-29 $0.505 $0.523 $0.495 $0.500 156 752
2022-07-28 $0.500 $0.509 $0.481 $0.504 121 209
2022-07-27 $0.510 $0.510 $0.481 $0.508 245 522
2022-07-26 $0.500 $0.505 $0.480 $0.485 211 582
2022-07-25 $0.524 $0.547 $0.510 $0.510 236 925
2022-07-22 $0.543 $0.564 $0.531 $0.540 79 208
2022-07-21 $0.562 $0.562 $0.540 $0.559 71 863
2022-07-20 $0.575 $0.575 $0.554 $0.558 51 758
2022-07-19 $0.550 $0.584 $0.540 $0.554 147 877
2022-07-18 $0.559 $0.560 $0.538 $0.545 87 706
2022-07-15 $0.520 $0.570 $0.520 $0.541 47 452
2022-07-14 $0.551 $0.570 $0.543 $0.543 42 090
2022-07-13 $0.560 $0.585 $0.546 $0.570 67 728
2022-07-12 $0.580 $0.594 $0.544 $0.571 84 490
2022-07-11 $0.553 $0.582 $0.542 $0.572 73 973
2022-07-08 $0.593 $0.593 $0.565 $0.571 118 897
2022-07-07 $0.535 $0.581 $0.535 $0.578 299 515
2022-07-06 $0.537 $0.548 $0.532 $0.539 116 339
2022-07-05 $0.525 $0.530 $0.525 $0.527 28 612
2022-07-01 $0.530 $0.540 $0.495 $0.530 294 428
2022-06-30 $0.525 $0.540 $0.510 $0.530 157 719
2022-06-29 $0.530 $0.539 $0.520 $0.533 54 993
2022-06-28 $0.525 $0.541 $0.525 $0.526 213 867
2022-06-27 $0.520 $0.530 $0.520 $0.521 108 078
2022-06-24 $0.520 $0.538 $0.490 $0.500 222 069
Click to get the best stock tips daily for free!

About Caladrius Biosciences

Caladrius Biosciences Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysf... CLBS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT